SCHEMBL18156893

SCHEMBL18156893

CCOC(C)(C)c1ccc(N)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.48
NPC1 O15118 3/20 0.48
RAB9A P51151 3/20 0.48
MAPK1 P28482 4/20 0.45
ALDH1A1 P00352 3/20 0.45
HPGD P15428 1/20 0.45
TDP1 Q9NUW8 4/20 0.45
TSHR P16473 3/20 0.45
CYP3A4 P08684 3/20 0.38
LMNA P02545 1/20 0.38
CYP1A2 P05177 1/20 0.38
MAOA P21397 1/20 0.38
KIF11 P52732 1/20 0.35
PSMD14 O00487 1/20 0.35
RECQL P46063 1/20 0.35
GFER P55789 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
MAOB P27338 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2816581 0.89 MAPK1 (0.40) MAPTNPC1RAB9AMAPK1ALDH1A1
SCHEMBL18156896 0.83 MAPT (0.46) MAPTNPC1RAB9AMAPK1ALDH1A1
SCHEMBL19144067 0.82 ESR1 (0.42) MAPTMAPK1ALDH1A1HPGDTSHR
SCHEMBL18156894 0.80 MAPT (0.47) MAPTNPC1RAB9AMAPK1ALDH1A1
SCHEMBL10534242 0.80 TSHR (0.48) MAPTNPC1RAB9AMAPK1ALDH1A1
SCHEMBL27496872 0.79 NPC1 (0.46) MAPTNPC1RAB9AMAPK1ALDH1A1
SCHEMBL16451453 0.78 APP (0.42) MAPTNPC1RAB9AMAPK1ALDH1A1
SCHEMBL4573159 0.78 CYP2A6 (0.35) MAPTNPC1RAB9AMAPK1ALDH1A1
SCHEMBL18905523 0.78 MAPK1 (0.33) MAPK1ALDH1A1
SCHEMBL43427 0.77 MAPK1 (0.58) MAPTMAPK1ALDH1A1CYP3A4KIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9738600-B2 ROR gamma (RORγ) modulators LEAD PHARMA CEL MODELS IP B.V. (NL) 2017-08-22 US disclosed
US-20160304448-A1 ROR GAMMA (RORy) MODULATORS LEAD PHARMA CEL MODELS IP B.V. (NL) 2016-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160304448-A1 ROR GAMMA (RORy) MODULATORS RORC, RORA, RORB MAPT 4664/4885NPC1 1281/4885RAB9A 1093/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.